FIRST (Fractional Flow Reserve and Intravascular Ultrasound Relationship Study) aimed to determine the optimal minimum lumen area (MLA) by intravascular ultrasound (IVUS) that correlates with fractional flow reserve (FFR) and to assess the correlation between virtual histology IVUS and FFR for intermediate coronary lesions.
For patients who present with intermediate coronary stenosis, defined angiographically as 40% to 80% luminal narrowing, the appropriate criteria for revascularization have been under debate. The estimation of the degree of stenosis with visual estimation via angiography or quantification by quantitative coronary angiography (QCA) is imprecise (1) . Additionally, the functional significance of these intermediate lesions is often not established; therefore, revascularization is not necessary. Fractional flow reserve (FFR) is considered to be the gold standard modality to evaluate the pathology of such lesions with regard to their association with ischemia (2) (3) (4) . The predominant intracoronary im-
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aging/assessment tool is intravascular ultrasound (IVUS), which is mainly used for lesion anatomic/morphological assessment and often to optimize stent deployment. The capabilities of IVUS imaging in facilitating the decision process with regard to the need for revascularization based on the contribution of the lumen diameter stenosis to ischemia has only been reported in retrospective analyses and is in question (5) (6) (7) (8) .
To date, available data regarding the relationship between anatomic IVUS parameters and functional FFR results have been from retrospective data analyses and are variable. Additionally, the optimal minimal lumen area (MLA) cutoff value by IVUS for FFR Ͻ0.80 has not been well established (5,9 -11) . The traditional cutoff has been 4.0 mm 2 MLA; however, recent publications have deemed this cutoff to be too generous. Several studies reported different MLA cutoffs for different vessel diameters (5, (9) (10) (11) . However, these series were all retrospective, and the majority had small sample sizes and did not include correlation of plaque morphology or plaque burden with FFR. To date, the optimal cutoff for IVUS MLA to best correlate with FFR Ͻ0.8 has yet to be determined, as is the question of whether IVUS MLA can be a reliable alternative to FFR in determining the functional status of intermediate lesions.
FIRST (Fractional Flow Reserve and Intravascular Ultrasound Relationship Study) was designed to determine the correlation between FFR, IVUS, and virtual histology (VH) IVUS in a multinational, multicenter, prospective registry of a large patient cohort with intermediate coronary stenosis and to integrate the anatomic IVUS criteria and VH and plaque burden parameters that correlate with ischemic FFR.
Methods
Study design, population, and endpoints. FIRST was designed as a multicenter, prospective registry of patients who underwent elective coronary angiography and had intermediate coronary stenosis defined as stenosis of 40% to 80% by visual estimation at 1 or more major epicardial coronary arteries. From July 2010 to December 2011, 350 patients (367 intermediate lesions) were assessed by QCA, IVUS gray scale, VH IVUS, and FFR. Exclusions included patients with myocardial infarction within 72 h, saphenous vein graft lesions, with lesions in vessels with Ͻ2.5-mm reference vessel diameter (RVD), or with Ͼ1 lesion in the studied vessel. Written informed consent for all procedures was obtained from each patient. Additional clinical data regarding medical history, particularly cardiac risk factors and left ventricular function, were also collected. QCA analysis. QCA analysis was performed by an independent technician blinded to the results of both IVUS and FFR. A computer-assisted, automatic contour detection technique (CAAS 5.9.2 Quantitative Coronary Angiography for Research, Pie Medical Imaging BV, Maastricht, the Netherlands) was used. The outer diameter of the contrastfilled catheter served as the calibration standard. After selection of the optimal projection displaying the most severe stenosis, the percentage of diameter stenosis at end-diastole, minimal lumen diameter, RVD, and lesion length were measured. Lesion length was calculated as the distance between the proximal and distal reference in the projection demonstrating the stenosis with the least foreshortening. IVUS analysis. IVUS/VH IVUS studies were performed using the Volcano Corporate Eagle Eye Platinum IVUS catheter (San Diego, California), which incorporates a phased array immobile set of crystals arranged circularly around the catheter and was activated sequentially at 20 MHz. All IVUS/VH images were recorded after the administration of 150 to 200 g intracoronary nitroglycerin.
The transducer was pulled back from the distal coronary artery through the target stenosis and to the proximal portion at 0.5 or 1.0 mm/s. Images were recorded on DVDs for analysis by an independent core laboratory. Quantitative analysis of the IVUS gray-scale images was performed by a skilled interpreter using computerized planimetry with Volcano Imaging Software 3.0.422 (Volcano Corporation), and the VH IVUS images were analyzed using Echoplaque 4.0.17 (INDEC Systems, Inc., Mountain View, California). Lumen cross sections were measured at the most stenotic site with the smallest lumen. Data were analyzed on various IVUS parameters including, but not limited to, the minimal lumen diameter, MLA, lesion length, area stenosis, and elastic membrane area. The area stenosis was calculated as the reference lumen area minus the MLA divided by reference lumen area. Gray-scale IVUS and VH IVUS data were collected to define plaque composition, including the percentage of necrotic core, dense calcium, and plaque-type presence. The definition of thin cap fibroatheroma (TCFA) was a confluent necrotic core Ͼ10% of the total plaque, no evidence of fibrotic plaque in direct contact with the lumen, with dense calcium Ͼ5% and plaque burden Ͼ40%. FFR analysis. To assess FFR, a 0.014-inch pressure guide wire (Volcano Corporation or Radi Medical System, Uppsala, Sweden) was deployed. Distal pressure was measured immediately distal to the distal edge of the stenosis during a period of maximum hyperemia induced by intravenous adenosine (140 g/kg/min for the right coronary artery and 180 g/kg/min for the left coronary artery). Aortic pressure was measured through the guiding catheter (6-or 7-F). FFR was calculated as the ratio of the coronary pressure distal to the lesion measured by the pressure wire to the mean aortic pressure measured by the guiding catheter. Based on the results of these 3 methods, the analyses correlated the IVUS and QCA parameters with FFR results. Percutaneous coronary intervention (PCI) was not mandatory and was left to the operator's discretion. Tables 1 and 2 . The mean age of the patients was 61.4 Ϯ 10.9 years; 260 (74.3%) patients were male. Of the 367 lesions, 210 (57.2%) were located in the left anterior descending artery territory. In 100 (27.2%) stenoses, FFR was Ͻ0.8.
The relationship of FFR with the IVUS parameter of MLA was compared graphically in a scatterplot detailed in Figures 1A through 1D . There was a moderate correlation between FFR and MLA overall, with variable correlation given to the RVD. For the lesions located in the lower right quadrant of Figure 1A (lesions with FFR Ͻ0.8 and MLA Ͼ3.07), 67.7% of lesions (21 of 31) underwent PCI. For the 10 lesions that did not undergo PCI, the median MLA was 4.45 mm 2 with a median FFR of 0.77. The breakdown by RVD demonstrated an improvement in correlation between MLA and FFR with the increase in vessel diameter. The weakest correlation was for RVDs of 2.5 to 3.0 mm (r ϭ 0.22, p ϭ 0.003) with a gradual increase in correlation with 3.0 to 3.5 mm and slightly more with Ͼ3.5-mm vessels (r ϭ 0.27, p ϭ 0.01 and r ϭ 0.34, p ϭ 0.007, respectively). There was a difference in correlation between lesions with a thin-capped fibroatheroma (TCFA) or calcified TCFA (CaTCFA) versus none (r ϭ 0.25, p ϭ 0.01 and r ϭ 0.32, p Ͻ 0.0001). Interestingly, there was a stronger correlation between MLA and FFR in those lesions without the presence of a TCFA or CaTCFA. This analysis is limited, however, because the resolution for the VH-IVUS may not account for the identification of TCFA Ͻ200 m.
Baseline Clinical and Lesion-Specific Characteristics Values are mean Ϯ SD or n (%). (AUC ϭ 0.68) in lesions with RVDs Ͼ3.5 mm (Fig. 2) .
Angiographic and Intravascular Ultrasound Parameters
Given the optimal cutoff values for MLA to FFR Ͼ0.8, the false-positive rate in the overall population was 25.7%. The rate was 24.0% for the vessels Ͻ3.0 mm and slightly better for vessels 3.0 to 3.5 mm and Ͼ3.5 mm given their cutoff values of 18.5% and 22.6%, respectively. The falsenegative rate, given the same cutoff values, was 9.6% for the overall population of lesions and ranged from 9.7% to 10.9% for the RVD breakdown. ROC analysis was also performed for TCFA or CaTCFA and no TCFA or CaTCFA with (AUC ϭ 0.62 and 0.65, respectively).
The VH IVUS findings by FFR are shown in Table 3 . The mean overall plaque burden was 68.7 Ϯ 11.2% and was the only VH IVUS variable that correlated with FFR Ͻ0.8. 
Plaque burden was higher in FFR

Discussion
FIRST is the first prospective, multinational, multicenter registry to examine the correlation of anatomic IVUS and VH IVUS criteria with physiological FFR values to deter- (3, 12) .
Currently, FFR is used in routine clinical practice as a diagnostic test to determine whether intervention should be performed in those lesions. Over the years, the use of IVUS has been established to assess lesion and plaque morphology and has been proven to optimize stent implantation with the potential to reduce the rates of subacute stent thrombosis (13) (14) (15) . The attempt to use the anatomic findings to Abbreviations as in Figure 1 .
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determine the functional significance of intermediate lesions was first reported in 1999, and an MLA of Ͻ4 mm 2 was suggested as the cutoff threshold for intervention (7) .
Over the past 2 years, numerous publications have challenged the use of IVUS MLA criteria to identify those intermediate lesions that are ischemic. Recent retrospective analyses of patients who underwent both IVUS and FFR for these intermediate lesions have suggested a weak correlation between the 2 modalities, with an IVUS MLA cutoff ranging from 2.5 to 3.6 mm 2 for an FFR Ͻ0.8. Vessel size and lesion location, which affect the amount of myocardium subjected to ischemia, were also taken into consideration. As a result, different cutoffs for IVUS MLA were suggested for large vessels, such as an unprotected left main or proximal left anterior descending coronary artery, and small vessels, such as distal lesions involving small areas of myocardium.
Previous publications by Ben-Dor et al. (10, 11) , Kang et al. (5) , and Koo et al. (12) reported different accuracies of and correlation with FFR for these vessel size/locationdependent cutoff values for IVUS MLA. However, these studies were retrospective with relatively small patient cohorts. These studies did not take into account the potential impact of plaque morphology. Additionally, these studies did not include either IVUS or QCA core laboratories, and there were various protocols for administering adenosine to induce hyperemia, both intracoronary and peripheral. FIRST was designed to overcome these limitations by incorporating a unified methodology for IVUS and FFR. Both QCA and IVUS/VH analyses were performed by independent core laboratories. In FIRST, the cutoff for the entire cohort was Ͻ0.8 and 3.07 mm 2 for the IVUS MLA with a sensitivity of 64.0% and specificity of 64.9%. The correlation and accuracy increased in larger vessel sizes. However, this cutoff varied from 2.7 mm 2 for vessels 2.5 to 3.0 to 3.2 mm in diameter up to 3.7 mm 2 for vessels Ͼ3.5 mm in diameter. Therefore, we propose the use of different cutoffs of IVUS MLA based on the measured RVD.
Interestingly, plaque morphology did not correlate with FFR values and most likely will not contribute to determining the level of ischemia generated by the lesion. Plaque burden was greater in patients with an FFR Ͻ0.80; however, this was expected and can be explained by its contribution to the decrease in lumen diameter and smaller IVUS MLA.
Given the modest correlation of IVUS MLA with FFR and the variability in cutoffs, the key question is whether IVUS-derived indexes should be used to guide intervention versus deferral of intermediate lesions. If anatomically feasible, IVUS could be used to guide the decision pathway regarding the need for PCI of intermediate lesions, in addition to lesion assessment, stent and selection optimization, and stent deployment. FIRST and previous publications, however, suggest that the accuracy in detecting functional intermediate lesions with IVUS MLA is not optimal and is only ϳ70%.
FFR also has accuracy issues, especially in patients with ischemia and myocardial dysfunction (16, 17) . Given the limitations of both modalities, the operator should use these tools only to support his or her clinical judgment. As seen in FIRST and in previous studies, it is rare to find FFR Ͻ0.8 with an MLA Ͼ4.0 mm 2 . In the case of stable patients with false-negative FFR, medical therapy will most likely be adequate. The use of IVUS MLA would likely be associated with more false-positive outcomes than FFR and would overestimate the severity of the lesions, which could result in increased stent use that would be avoided if the lesion were assessed by FFR. A study comparing FFR with IVUS based on an IVUS MLA cutoff of 4.0 mm 2 performed in 167 patients with 1-year follow-up had similar and favorable outcomes irrespective of the guiding strategy; however, the FFR-guided lesion assessment reduced the need for revascularization for many lesions compared with the IVUSguided strategy (18) .
Therefore, we suggest that if a study design like that of FAME (Fractional Flow Reserve Versus Angiography in Multivessel Evaluation) is performed based on IVUS rather than FFR, it is possible that the results will be the same as published for FAME (13) , despite some increase in revascularization when determined by the IVUS criteria. To address the question of which assessment is most appropriate, a large randomized clinical trial comparing the assessment based on IVUS criteria with FFR is warranted. Until such a study is conducted, physicians should primarily use their clinical judgment and FFR because FFR is the most accurate tool to detect ischemia. However, adequate IVUS-MLA cutoff values should be considered as an alternative to FFR in addition to the role of IVUS. Study limitations. In FIRST, the decision for PCI was at the discretion of the investigator and was not dictated by protocol. Given that there were relatively few lesions with an FFR Ͻ0.8 and an MLA Ͻ4.0 mm 2 that did not undergo PCI, as well as even fewer lesions with an FFR Ͼ0.8 and an MLA Ͼ4.0 mm 2 that underwent PCI, it is clear that the investigators did not exclusively use either tool as a guide for interventional necessity. Therefore, FIRST is limited with respect to the impact of correlation between the 2 modalities on clinical outcome. 
